Peer review reports
From: Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
| Original Submission |
| 10 Jun 2015 |
Submitted |
Original manuscript
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
| Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
| Publishing |
| 16 Oct 2015 |
Editorially accepted |
|
| 27 Oct 2015 |
Article published |
10.1186/s12885-015-1825-5
|
Learn about peer review
